Genomic characterisation of respiratory syncytial virus: a novel system for whole genome sequencing and full-length G and F gene sequences

Iglesias-Caballero, M.; Camarero-Serrano, S.; Varona, S.; Mas, V.; Calvo, C.; García, M.L.; García Costa, Juan; Vázquez-Morón, S.; Monzón, S.; Campoy, A.; Cuesta, I.; Pozo, F.; Casas, I.

doi:10.2807/1560-7917.es.2023.28.49.2300637

Iglesias-Caballero, M.; Camarero-Serrano, S.; Varona, S.; Mas, V.; Calvo, C.; García, M.L.; García Costa, Juan; Vázquez-Morón, S.; Monzón, S.; Campoy, A.; Cuesta, I.; Pozo, F.; Casas, I.

Estadísticas

Ver Estadísticas de uso

Identificadores

URI: http://hdl.handle.net/20.500.11940/21536

DOI: 10.2807/1560-7917.es.2023.28.49.2300637

ISSN: 1560-7917

Registro completo

Servicios

Visualización o descarga de ficheros

Iglesias-Caballero M, Camarero-Serrano S, Varona S, Mas V, Calvo C, García ML, et al. Genomic characterisation of respiratory syncytial virus: a novel system for whole genome sequencing and full-length G and F gene sequences. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin. 2023;28(49). (459.3Kb)

Fecha de publicación

2023

Título de revista

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin

Tipo de contenido

Artigo

MeSH

Resumen

To advance our understanding of respiratory syncytial virus (RSV) impact through genomic surveillance, we describe two PCR-based sequencing systems, (i) RSVAB-WGS for generic whole-genome sequencing and (ii) RSVAB-GF, which targets major viral antigens, G and F, and is used as a complement for challenging cases with low viral load. These methods monitor RSV genetic diversity to inform molecular epidemiology, vaccine effectiveness and treatment strategies, contributing also to the standardisation of surveillance in a new era of vaccines.

Excepto si se señala otra cosa, la licencia del ítem se describe como Attribution 4.0 International (CC BY 4.0)

Repositorio digital RUNA